Aresgado, Concordia .

HRN: 27-62-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2025
CEFTRIAXONE 1G (VIAL)
08/12/2025
08/19/2025
IV
2 Grams
IV
Cap MR
Remove - Pending Acceptance
08/12/2025
AZITHROMYCIN 500MG TABLET (TAB)
08/12/2025
08/19/2025
TAB
500
Q24
CAP MR
Remove - Pending Acceptance
08/23/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/23/2025
08/30/2025
IV
2.25g
Q6
CAPmr
Remove - Pending Acceptance
08/26/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/26/2025
09/02/2025
IVT
2.25g
Q8
Cap Mr
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: